Literature DB >> 24995484

Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral-domain optical coherence tomography.

Hasan Ali Bayhan1, Seray Aslan Bayhan, Asuman Celikbilek, Nermin Tanık, Canan Gürdal.   

Abstract

BACKGROUND: To assess the chorioretinal thickness changes using spectral-domain optical coherence tomography (SD-OCT) and to evaluate the association between these structural changes and cognitive impairment in Alzheimer's disease (AD).
DESIGN: Prospective, cross-sectional study PARTICIPANTS: Thirty-one eyes of 31 consecutive patients with AD and 30 eyes of 30 cognitively healthy age-matched control subjects were recruited
METHODS: SD-OCT (RTVue-100) was used to measure the macular ganglion cell complex thickness (mGCC), outer retinal thickness (ORL), and the choroidal thickness (CT). Cognitive function was evaluated by Mini-Mental State examination (MMSE) on the same day of the optical examination. MAIN OUTCOME MEASURES: Chorioretinal thickness.
RESULTS: The mGCC average, mGCC superior and mGCC inferior thicknesses of the AD group were significantly thinner than those of the controls (all, P < 0.05). No significant difference was found in the ORL thickness measurements between the two groups. Compared with control subjects, the CT measurements at all regions were significantly thinner in patients with AD than controls except CT measurement at 3.0 mm temporal to the fovea (P = 0.067). Significant correlations between the mGCC thickness measurements of the AD group and MMSE scores were observed. There was no significant correlation between the MMSE scores and the CT measurements (P > 0.05).
CONCLUSIONS: Patients with AD had chorioretinal structural alterations. Retinal structural alterations were seen only in the inner layers. The reduction in mGCC thickness parameters were related to the severity of cognitive impairment in AD.
© 2014 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  Alzheimer's disease; choroidal thickness; ganglion cell complex; spectral-domain optical coherence tomography

Mesh:

Year:  2014        PMID: 24995484     DOI: 10.1111/ceo.12386

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  41 in total

1.  Peripapillary and macular choroidal thickness before and after phenylephrine instillation.

Authors:  Alfonso Casado; Alicia López-de-Eguileta; Jorge Gaitán; Soraya Fonseca; Miguel A Gordo-Vega
Journal:  Eye (Lond)       Date:  2019-06-04       Impact factor: 3.775

Review 2.  [Retinal imaging of the macula and optic disc in neurodegenerative diseases].

Authors:  G N Turski; S Schmitz-Valckenberg; F G Holz; R P Finger
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

Review 3.  Optical Coherence Tomography of Choroid in Common Neurological Diseases.

Authors:  Federico DI Staso; Marco Ciancaglini; Solmaz Abdolrahimzadeh; Fabian D'Apolito; Gianluca Scuderi
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

4.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

Authors:  Yosef Koronyo; David Biggs; Ernesto Barron; David S Boyer; Joel A Pearlman; William J Au; Shawn J Kile; Austin Blanco; Dieu-Trang Fuchs; Adeel Ashfaq; Sally Frautschy; Gregory M Cole; Carol A Miller; David R Hinton; Steven R Verdooner; Keith L Black; Maya Koronyo-Hamaoui
Journal:  JCI Insight       Date:  2017-08-17

5.  Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.

Authors:  Lauren M Wright; Thor D Stein; Gyungah Jun; Jaeyoon Chung; Kate McConnell; Marissa Fiorello; Nicole Siegel; Steven Ness; Weiming Xia; Kelley L Turner; Manju L Subramanian
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 6.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis.

Authors:  Victor T T Chan; Zihan Sun; Shumin Tang; Li Jia Chen; Adrian Wong; Clement C Tham; Tien Y Wong; Christopher Chen; M Kamran Ikram; Heather E Whitson; Eleonora M Lad; Vincent C T Mok; Carol Y Cheung
Journal:  Ophthalmology       Date:  2018-08-13       Impact factor: 12.079

Review 8.  Alzheimer's disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo.

Authors:  J P Cunha; N Moura-Coelho; R P Proença; A Dias-Santos; J Ferreira; C Louro; A Castanheira-Dinis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

9.  Relationships between retinal layer thickness and brain volumes in the UK Biobank cohort.

Authors:  Sharon Y L Chua; Gerassimos Lascaratos; Denize Atan; Bing Zhang; Charles Reisman; Peng T Khaw; Stephen M Smith; Paul M Matthews; Axel Petzold; Nicholas G Strouthidis; Paul J Foster; Anthony P Khawaja; Praveen J Patel
Journal:  Eur J Neurol       Date:  2021-01-20       Impact factor: 6.089

Review 10.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.